Division of Hematology/Oncology


faculty photo

Jakub Svoboda, MD

Assistant Professor of Medicine at the Hospital of the University of Pennsylvania
Data Safety and Monitoring Committee , Abramson Cancer Center
Department: Medicine

Contact information
Perelman Center for Advanced Medicine
2 West Pavilion
3400 Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-614-1846
Fax: 215-615-5888
B.A. (Biology)
Mercyhurst College (Erie, PA), 1994.
M.D. (Medicine)
Yale University School of Medicine, 2000.
Post-Graduate Training
Intern in Medicine, University of Pennsylvania, 2000-2001.
Resident in Medicine, University of Pennsylvania, 2001-2003.
Fellow in Hematology-Oncology, University of Pennsylvania, 2003-2006.
American Board of Internal Medicine, 2003.
American Board of Internal Medicine (Medical Oncology), 2006.
American Board of Internal Medicine (Hematology), 2007.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Shah Nirav N, Harrison Neil, Stonecypher Mark, Frank Dale, Amorosa Valerianna, Svoboda Jakub: Extracavitary primary effusion lymphoma initially presenting with hemophagocytic lymphohistocytosis. Clinical lymphoma, myeloma & leukemia 14(5): e157-60, Oct 2014.

Nagle Sarah J, Chong Elise A, Chekol Seble, Shah Nirav N, Nasta Sunita D, Glatstein Eli, Plastaras John P, Torigian Drew A, Schuster Stephen J, Svoboda Jakub: The role of FDG-PET imaging as a prognostic marker of outcome in primary mediastinal B-cell lymphoma. Cancer medicine Sep 2014.

Frosch Zachary, Luskin Marlise R, Landsburg Daniel J, Schuster Stephen J, Svoboda Jakub, Loren Alison W, Porter David L, Stadtmauer Edward A, Nasta Sunita D: R-CHOP or R-HyperCVAD With or Without Autologous Stem Cell Transplantation for Older Patients With Mantle Cell Lymphoma. Clinical lymphoma, myeloma & leukemia Aug 2014.

Landsburg Daniel J, Nasta Sunita D, Svoboda Jakub, Morrissette Jennifer J D, Schuster Stephen J: 'Double-Hit' cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients. British Journal of Haematology 166(3): 369-74, Apr 2014.

Ahmadi Tahamtan, Chong Elise A, Gordon Amanda, Aqui Nicole A, Nasta Sunita D, Svoboda Jakub, Mato Anthony R, Schuster Stephen J: Combined lenalidomide, low-dose dexamethasone, and rituximab achieves durable responses in rituximab-resistant indolent and mantle cell lymphomas. Cancer 120(2): 222-8, Jan 2014.

Nagle, SJ, Woo, K, Schuster, SJ, Nasta, SD, Stadtmauer, E, Mick, R, Svoboda, J: Outcomes of patients with relapsed/refractory diffuse large B-cell lymphoma with progression of lymphoma after autologous stem cell transplantation in the rituximab era. American Journal of Hematology 88(10): 890-894, OCT 2013.

Patel, V, Buckstein, M, Perini, R, Hill-Kayser, C, Svoboda, J, Plastaras, JP: Computed tomography and positron emission tomography/computed tomography surveillance after combined modality treatment of supradiaphragmatic Hodgkin lymphoma: a clinical and economic perspective. Leukemia and Lymphoma 54(10): 2168-2176, OCT 2013.

Ahmadi T, McQuade J, Porter D, Frey N, Loren A W, Goldstein S C, Svoboda J, Stadtmauer E, Schuster S J, Nasta S D: Potential prolongation of PFS in mantle cell lymphoma after R-HyperCVAD: auto-SCT consolidation or rituximab maintenance. Bone Marrow Transplantation 47(8): 1082-6, Aug 2012.

Mato, AR, Svoboda, J, Feldman, T, Zielonka, T, Agress, H, Panush, D, Miller, M, Toth, P, Lizotte, PM, Nasta, S, Goldberg, S, Chong, E, Schuster, S, Pecora, AL, Goy, A: Post-treatment (not interim) positron emission tomography-computed tomography scan status is highly predictive of outcome in mantle cell lymphoma patients treated with R-HyperCVAD. Cancer 118(14): 3565-3570, JUL 15 2012.

Tsai Donald E, Chong Elise, Bagg Adam, Arnoldi Sharon, Svoboda Jakub, Nasta Sunita, Schuster Stephen J: Successful treatment of angioimmunoblastic T-cell lymphoma with the retinoid X receptor agonist, bexarotene. Leukemia and Lymphoma 52(9): 1815-7, Sep 2011.

back to top
Last updated: 11/05/2014
The Trustees of the University of Pennsylvania

Clinical Briefings Blog Spot

Penn MD Forum title with Penn Medicine Shield and Twitter